The vascular parkinsonism market is forecasted to grow from USD 319.5 million in 2025 to USD 538.1 million by 2035, at a CAGR of 6.20% during the forecast period. The growth is being driven by the ...

People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...

The modern boxing comeback is a perfect storm where the fighter’s timeless need for purpose has collided with an economy that ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

This Case Study describes a 80-year-old patient with lower-body parkinsonism who was diagnosed with vascular parkinsonism on the basis of clinical and neuroimaging findings, but whose gait and, to ...

“Declining gait speed may signal early cognitive decline and structural brain ageing,” he said. “It can help detect ...

Faster α-synuclein seeding in cerebrospinal fluid signaled a higher risk of cognitive decline in Parkinson’s disease.

About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat ...

Dystonia involves involuntary muscle contractions, but you're not out of options. Discover how botulinum toxin, DBS, and ...

July 10, 2025 Stephen Braun, 65 of Winnipeg formerly of Altona passed away Tuesday, July 1st in Winnipeg. He is survived by ...